|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Characterization and device applications of ZnO films deposited by high power impulse magnetron sputtering (HiPIMS) 显示文摘 | Partridge J G Mayes E L H McDougall N L | 2013 | J Phys D: Appl Phys2013，46，16： | 1 |
| 2 | Microbubble ultrasound improves the efficiency of gene transduction in skeletal muscle in vivo with reduced tissue damage 显示文摘 | LU Q L LIANG H D PARTRIDGE T | 2003 | Gene Ther2003，10，19： | 1 |
| 3 | Towards tacit knowledge sharing over social Web tools 显示文摘 | PANAHI S WATSON J PARTRIDGE H | 2013 | Journal of Knowledge Management2013，17，3： | 1 |
| 4 | 早期乳腺癌最佳辅助化疗方案与人类表皮生长因子受体2阳性乳腺癌辅助靶向治疗选择:依据 ASCO 对 CCO临床实践指南的改编显示文摘目的研究加拿大安大略癌症治疗中心(CCO)关于早期乳腺癌最佳辅助化疗方案,包括人类表皮生长因子受体2(HER2)阳性乳腺癌辅助靶向治疗方案,并对其进行改编。方法按照美国临床肿瘤协会(ASCO)对其他组织临床实践指南改编的策略和程序,对CCO临床实践指南的严谨性与内容适用性进行回顾。结果基于对CCO临床实践指南内容的回顾,ASCO小组认为,CCO临床实践指南在整体上清晰全面,以最确切的科学证据为基础,为患者提供可接受的治疗选项。推荐关于辅助化疗方案的决定,应考虑到基线复发风险、毒性、利益可能性和宿主因素(如合并症)。对于高风险HER2阴性的身体状况良好的人群,蒽环类和紫杉烷治疗方案是标准治疗方案。4个周期的多西他赛和环磷酰胺治疗方案是可接受的非蒽环类治疗方案。对于高风险HER2阳性患者,推荐蒽环类与紫杉烷序贯疗法联合曲妥单抗或多西他赛、卡铂、曲妥单抗进行6个周期的治疗。对于低风险、非淋巴结转移、HER2阳性人群,推荐每周一次的紫杉醇和曲妥单抗连续进行12个周期的替代治疗。曲妥单抗应持续使用1年。不应采用铂复合盐对三阴性人群进行常规的辅助管理,除非出现有效的生存数据加以支持。 | Neelima Denduluri Mark R Somerfield Andrea Eisen Jamie N Holloway Arti Hurria Tari A King Gary H Lyman Ann H Partridge Melinda L Telli Maureen E Trudeau Antonio C Wolff 本刊编辑部 | 2016 | 中国全科医学2016，19，18： | 1 |
| 5 | Modeling users' Web search behavior and their cognitive styles 显示文摘 | Kinley K Tjondronegoro D Partridge H | 2014 | Journal of the Association for Information Science and Technology2014，65，6： | 1 |
| 6 | Effects of some nonionic polyoxyethylene surfactants on uptake of ethirimol and dielobutrazol from suspension formulations applied to wheat leaves显示文摘 | Holloway P J Wong W C Partridge H J | 1992 | Pesticide Science1992，34，： | 1 |
| 7 | Towards tacit knowledge sharing over so- cial Web tools 显示文摘 | Panahi S Watson J Partridge H | 2013 | Journal of Knowledge Management2013，17，3： | 1 |
| 8 | Exploring modes of facilitative support for GDSS technology显示文摘 | Dickson G W Partridge J L Robinson L H | 1993 | MIS Quarterly1993，17，2： | 1 |
| 9 | Chemical-kinetic parameters of hyperbolic earth entry显示文摘 | Park C Jaffe R L Partridge H | | 0，，01： | 1 |
| 10 | Theoretical Study of the B3∑-u-X3∑-g and B'3πu-X3∑-g Band Systems of S2显示文摘 | Pradhan A D Partridge H | 1996 | Chem Phys Lett1996，255，123： | 1 |
| 11 | Towards tacit know- ledge sharing over social web tools显示文摘 | Panahi S Watson J Partridge H | 2013 | Journal of Knowledge Management2013，17，3： | 1 |
| 12 | Design of piezoresistive MEMS-based accelerometer for integration with wireless sensing unit for structural monitoring 显示文摘 | Lynch J P Partridge A Law K H | 2003 | Journal of Aerospace Enginee- ring2003，16，3： | 1 |
| 13 | The electronic excited states of BN 显示文摘 | Bauschlicher Jr C W Partridge H | 1996 | Chem Phys Lett1996，257，： | 1 |
| 14 | Potential energy curves and transport properties for the interaction of He with other ground state atoms显示文摘 | Partridge H Stallcop J R Levin E | 2001 | J Chem Phys2001，115，： | 1 |
| 15 | Clutch size显示文摘 | Godfray D C J Partridge L Harvey P H | 1990 | Annu Rev Ecol Syst1990，22，： | 1 |
| 16 | Pairing and phase separation in a polarized fermi gas显示文摘 | Partridge G B LI W H Kamar R I | 2006 | Science2006，311，5760： | 1 |
| 17 | (2012) In vivo assessment of ductal carcinoma in situ grade: a model incorporating dynamic contrast-enhanced and diffusion- weighted breast MR imaging parameters显示文摘 | Rahbar H Partridge SC Demartini WB | 2012 | Radiology2012，263，2： | 1 |
| 18 | Electroluminescence from polyvinylcarbazole films显示文摘 | Partridge R H | 1983 | Polymer1983，24，6： | 1 |
| 19 | The low-lying states of A1Cu and AIAg显示文摘 | Bausehlicher C W Langhoff Jr S R Partridge H | 1994 | J Chem Phys1994，100，2： | 1 |
| 20 | In vivo assessment of ductal carcinoma in situ grade : a model in- corporating dynamic contrast- enhanced and diffusion- weighted breast MR imaging parameters 显示文摘 | Rahbar H Partridge SC Demartini WB | 2012 | Radiology2012，263，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员